Clinical Trials Browser

Phase 1 × OTHER × CA-4948 × Clear all

NCT05187182 2026-03-18

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Phase 1 Recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT07107750 2026-02-04

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Phase 1 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms